• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT II ILIAC STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT II ILIAC STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number ETLW1616C124E
Health Effect - Clinical Codes Hemorrhage/Blood Loss/Bleeding (1888); No Consequences Or Impact To Patient (2199); Injury (2348)
Date of Event 06/25/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
An endurant stent graft system was implanted in the patient for the endovascular treatment of a 65 mm abdominal aortic aneurysm.It was reported that approximately 4 years and 4 months post index procedure, a ct showed the patient had a type ib endoleak in the left limb due to the graft limb no longer engaging with the left common iliac artery.The cause of the event is unknown.No additional clinical sequelae were reported and the patient will be monitored by their physician.
 
Additional Manufacturer Narrative
Intervention was completed where an endurant limb was implanted to resolve the type ib endoleak.Per the physician the cause was suspected to be related to disease progression.If information is provided in the future, a supplemental report will be issued.
 
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT II ILIAC STENT GRAFT
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
MDR Report Key7689438
Report Number2953200-2018-01024
Device Sequence Number756926
Product Code MIH
UDI-Device Identifier00613994991591
UDI-Public00613994991591
Combination Product (Y/N)N
Initial Reporter StateOH
Initial Reporter CountryUS
PMA/510(K) Number
P100021
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2014
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 10/03/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date01/27/2016
Device Model NumberETLW1616C124E
Device Catalogue NumberETLW1616C124E
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 06/25/2018
Supplement Date Received by Manufacturer08/09/2018
08/08/2018
Initial Report FDA Received Date07/16/2018
Supplement Report FDA Received Date09/03/2018
10/03/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age73 YR
-
-